Patients suffering from a rare form of acute lymphoblastic leukaemia (ALL) now have a new treatment option: BLINCYTO (Blinatumomab), an antibody derivative that activates the body’s own immune system specifically against the cancer cells. It helps immune cells to recognize ® and destroy cancer cells that previously evaded an immune response…